Intestinal permeability and antigliadin antibody test for monitoring adult patients with celiac disease

Digestive Diseases and Sciences

Volumn 52, Issue 5, 2007, Pages 1304-1309

  Vilela, Eduardo Garcia ^a   De Abreu Ferrari, Maria De Lourdes ^a   De Gama Torres, Henrique Osvaldo ^a   Martins, Fabiana Paiva ^a   Goulart, Eugênio Marcos Andrade ^a   Lima, Agnaldo Soares ^a   Da Cunha, Aloíso Sales ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Antibodies; Celiac disease treatment; Intestinal mucosa; Intestinal permeability; Monitoring

Indexed keywords

GLIADIN ANTIBODY; GLUTEN; IMMUNOGLOBULIN A; LACTULOSE; MANNITOL;

ADULT; AGED; ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLIADIN ANTIBODY TEST; GLUTEN FREE DIET; HUMAN; IMMUNOLOGICAL PROCEDURES; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY TEST; MALE; PATHOPHYSIOLOGY; PATIENT MONITORING; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; CASE-CONTROL STUDIES; CELIAC DISEASE; DIET, PROTEIN-RESTRICTED; FEMALE; FOLLOW-UP STUDIES; GLIADIN; HUMANS; IMMUNOGLOBULIN A; INTESTINAL ABSORPTION; LACTULOSE; MALE; MANNITOL; MIDDLE AGED; PERMEABILITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 34247188630     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9511-8     Document Type: Article

References (40)

1. Corazza GR, Frisoni M, Treggiari EA, Valentini RA, Filipponi C, Volta U, Garban G (1993) Subclinical celiac sprue increasing occurrence and clues to its diagnosis. J Clin Gastroenterol 16:16-21
2. Vilela EG, Ferrari MLA, Bambirra EA, Barbosa AJA, Filho GB, Toppa NH, Goulart EA, Cunha AS (2002) Agreement between pathologists concerning assessment of intestinal biopsies from adult celiac disease patients. Gastroenterol Int 15:1-8
3. Bjarnason I, Macpherson A, Hollander D (1995) Intestinal permeability: an overview. Gastroenterology 108:1566-1581
4. DeMeo MT, Mutlu EA, Keshavarzian A, Tobin MC (2002) Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol 34:385-396
5. Rostami K, Kerckhaert J, Tiemessen R, von Blomberg BM, Meijer JW, Mulder CJ (1994) Sensitivity of aniendomysium and antigliadin antibodies in untreated celiac disease. Am J Gastroenterol 94:888-894
6. Reeves GE, Burns C, Hall ST, Gleeson M, Lemmert K, Clancy RL (2000) The measurement of IgA and IgG transglutaminase antibodies in celiac disease: a comparison with current diagnostic methods. Pathology 32:181-185
7. Green PHR, Jabri B (2003) Coeliac disease. Lancet 362:383-391
8. Perry I, Iqbal T, Cooper B (2001) Intestinal permeability in coeliac disease. Lancet 358:1729-1730
9. Walker-Smith JA, Guandalini S, Schimitz J, Scherling DH, Visakorpi JK (1990) Revised criteria for diagnosis of coeliac disease. Arc Dis Child 65:909-911
10. Dickey W, Hughes DF, McMillan SA (2000) Reliance on serum endomysial antibody testing underestimates the true prevalence of celiac disease by one fifth. Scand J Gastroenterol 35:181-183
11. Farrell RJ, Kelly CP (2002) Celiac sprue. N Engl J Med 346:180-188
12. Quisel A, Gill JM, Westerberg D (2002) Guideline for diagnosis of celiac disease. Del Med J 74: 229-241
13. Kilander AF, Nilsson LA, Gillberg R (1987) Serum antibodies to gliadin in celiac disease after gluten withdrawal. Scand J Gastroenterol 22:29-34
14. Farrell RJ, Kelly CP (2001) Diagnosis of celiac sprue. Am J Gastroenterol 96:3237-3246
15. Menzies IS (1974) Absorption of intact oligosaccharide in health and disease. Biochem Soc Trans 2:1042-1047
16. Codben L, Dickinson RJ, Rothwell J, Axon ATR (1978) Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J 14:1960
17. Menzies IS, Laker MF, Pounder RE, Bull J, Heyer S, Wheelen PG (1979) Abnormal intestinal permeability to sugars in villous atrophy. Lancet 24:1107-1109
18. Travis S, Mensies IS (1992) Intestinal permeability: functional assessment and significance. Clin Sci 82:471-488
19. Hollander D (1992) The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease. Scand J Gastroenterol 27:721-726
20. Krugliak P, Hollander D, Schlaepfer CC, Nguyen H, Ma TY (1994) Mechanisms and sites of mannitol permeability of small and large intestine in the rat. Dig Dis Sci 39:796-801
21. Madara JL, Stafford J (1989) Interferon-gamma directly affects barrier function of cultured intestinal monolayers. J Clin Invest 83:724-727
22. Nash S, Stafford J, Madara JL (1988) The selective and superoxide independent disruption of intestinal epithelial tight junctions during leucocyte transmigration. Lab Invest 59:531-537
23. Ventura A, Magazzu G, Greco L (1999) Duration of exposure to gluten and risk for autoimmune disorders in celiac patients. Gastroenterology 117:303-310
24. Hollander D (2002) Crohn's disease, TNF-α, and the leaky gut. The chicken or the egg. Am J Gastroenterol 97:1867-1868
25. Vogelsang H, Schwarzenhofer M, Oberhuber G (1998) Changes in gastrointestinal permeability in celiac disease. Dig Dis 16:333-336
26. Perry I, Iqbal T, Cooper B (2001) Intestinal permeability in coeliac disease. Lancet 358:1729-1730
27. Bjarnasson I, Peters TJ (1983) A persistent defect in intestinal permeability in coelic disease demonstrated by a 51Cr-labelled EDTA absorption test. Lancet 12:323-325
28. Dieterich W, Ehnis T, Bauer M, Donner P, Voulta U, Riecken EO, Shuppan D (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3:797-801
29. van de Wal Y, Kooy Y, van Veelen P, Pena S, Mearin L, Papadopoulos G Koning F (1998) Selective deamination by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161:1585-1588
30. Molberg O, Mcadam SN, Korner R, Quarsten H, Kristiansen C, Marsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM (1998) Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4 713-717
31. Sollid LM (2002) Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2:647-655
32. Jensen K, Sollid LM, Scott H, Paulesen G, Kett K, Thorsby E, Lundin KE (1995) Gliadin-specific T cell responses in peripheral blood of healthy individuals involve T cells restricted by the celiac disease associated DQ2 heterodimer. Scand J Immunol 42:166-170
33. Fasano A, Not T, Wang W, Uzzau S, Berti I, Tommasini A, Goldblum SE (2000) Zonulin, a newly discovered modulator of intestinal permeability and its expression in celiac disease. Lancet 355:1518-1519
34. Uil JJ, Van Van Overbeek FM, Meyer JW, Mulder CJ, Heymans H (1996) Follow-up of treated celiac patients: sugar absorption test and intestinal biopsies compared. Eur J Gastroenterol Hepatol 8:219-223
35. Juby LD, Dixon MF, Axon AT (1987) Abnormal intestinal permeability and jejunal morphometry. J Clin Pathol 40:714-718
36. Duerksen DR, Wilhelm-Boyles C, Parry DM (2005) Intestinal permeability in long-term follow-up of patients with celiac disease on a gluten-free diet. Dig Dis Sci 50:785-790
37. Johnston SD, Smye M, Watson RGP (2001) Intestinal permeability and morphometric recovery in celiac disease. Lancet 358:259-260
38. Bjarnason I, Peters TJ (1984) In vitro determination of small permeability: demonstration of a persistent defect in patients with celiac disease. Gut 25:145-150
39. Werneck-Silva AL, Sipahi AM, Damião AOMC, Buchpigue CA, Iriya K, Laudanna AA (2001) Intestinal permeability in strongyloidiasis. Braz J Med Biol Res 34:353-357
40. Troncon LEA, Pires CR, Kraus AO, Iazigi N (1996) Estudo da permeabilidade intestinal pelo teste do 51Cr-EDTA: utilidade clínica na detecção de alterações estruturais do epitélio do intestino delgado. Arq Gastroenterol 33:66-73